MindMaze Therapeutics Holding S.A. (0QKQ.L) LSE

Currency In CHF

AD

Valuation

Market Cap39.64M
Enterprise Value31.98M
P/E RatioN/A
PEG RatioN/A
Price/Sales RatioN/A
Price/Book RatioN/A
Enterprise/RevenueN/A
Enterprise/EBITDAN/A

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit MarginN/A
Operating MarginN/A
AD

Management Effectiveness

Return On AssetsN/A
Return On EquityN/A

Income Statement

Revenue642,000
Revenue/ShareN/A
Gross Profit-1.05M
EBITDA-8.88M
Net Income-9.91M
Diluted EPS-0.48

Balance Sheet

Total Cash12.5M
Total Cash/ShareN/A
Total Debt1.9M
Total Debt/EquityN/A
Current RatioN/A
Book Value Per ShareN/A

Price History

52-Week Change-89.16
52-Week High8.24
52-Week Low0.23
Moving Average 50 Days1.68
Moving Average 200 Days2.58

Statistics

Average Volume219
Shares Outstanding10.39M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend RateN/A
Trailing Annual Dividend YieldN/A
Payout RatioN/A
Last Split Factor1:400
Last Split DateMay 05, 2023
AD